Success Metrics

Clinical Success Rate

77.8%

Based on 7 completed trials

Completion Rate

78%(7/9)

Active Trials

2(13%)

Results Posted

29%(2 trials)

Terminated

2(13%)

Phase Distribution

Ph phase_3

13%

Ph not_applicable

19%

Ph phase_2

13%

Ph phase_4

44%

Ph phase_1

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution15 total trials

Phase 1Safety & dosage

1(6.7%)

Phase 2Efficacy & side effects

2(13.3%)

Phase 3Large-scale testing

2(13.3%)

Phase 4Post-market surveillance

7(46.7%)

N/ANon-phased studies

3(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

70.0%

7 of 10 finished

Non-Completion Rate

30.0%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(7)

Terminated(3)

Other(3)

Detailed Status

Completed7

unknown3

Terminated2

Not yet recruiting1

Withdrawn1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

77.8%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (6.7%)

Phase 22 (13.3%)

Phase 32 (13.3%)

Phase 47 (46.7%)

N/A3 (20.0%)

Trials by Status

completed744%

not_yet_recruiting16%

terminated213%

unknown319%

withdrawn16%

recruiting16%

active_not_recruiting16%

Recent Activity

2 active trials

Showing 5 of 16

active_not_recruitingphase_4

Administration of Subcutaneous Teicoplanin in the Treatment of Osteoarticular Infections: Tolerance Study

NCT01815541

not_yet_recruitingnot_applicable

Comparison of Efficacy and Safety of Ceftazidime Avibactam Versus Extended Infusions of High Dose Meropenem in Patients of ACLF With Nosocomial Infections.

NCT06818565

View all 16 trials

Clinical Trials (16)

Showing 16 of 16 trials

NCT05914467Phase 4

TDM-optimized Teicoplanin Dosing Versus Standard of Care

Active Not Recruiting

NCT06426836Not Applicable

Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)

Recruiting

NCT04003818Phase 4

Efficacy and Safety of Teicoplanin in CDAD

Terminated

NCT01815541Phase 2

Administration of Subcutaneous Teicoplanin in the Treatment of Osteoarticular Infections: Tolerance Study

Completed

NCT06818565Not Applicable

Comparison of Efficacy and Safety of Ceftazidime Avibactam Versus Extended Infusions of High Dose Meropenem in Patients of ACLF With Nosocomial Infections.

Not Yet Recruiting

NCT04370145Phase 4

Antibiotics Treatment of Cholangitis Post-Kasai Portoenterostomy

Completed

NCT04341831Phase 3

Does Teicoplanin Powder Use In Lumbar Instrumentation Surgery Reduce Surgical Site Infection

Unknown

NCT02018094Phase 4

The Amputation Surgical Site Infection Trial (ASSIT)

Completed

NCT00428844Phase 2

Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci

Completed

NCT00925093Phase 1

Study of Antibiotics in Cerebrospinal Fluid Following Intravenous Injection

Withdrawn

NCT00024453Not Applicable

Teicoplanin in Treating Septicemia in Patients Who Are Receiving Chemotherapy Through a Central Venous Catheter

Unknown

NCT00430937Phase 3

Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections

Terminated

NCT00462878

Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation

Completed

NCT00454272Phase 4

Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients

Completed

NCT00719056Phase 4

Teicoplanin Prophylaxis for Total Hip or Knee Arthroplasty

Completed

NCT00368498Phase 4

A Trial to Evaluate the Loading Dose Required to Achieve Therapeutic Serum Teicoplanin Concentration Timely

Unknown

All 16 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 16